Maryann Selfe
WAYS OF WORKING

Institutional judgement for important investment decisions.

Women's health is attracting growing scientific, commercial and investor attention. Yet the market remains difficult to evaluate and institutional access is still developing.

For more than two decades, I worked across private banking, wealth and asset management, advising sophisticated investors on capital allocation, manager selection, portfolio construction and investment risk.

Today, I bring that institutional perspective to women's health. I work with investors and healthcare organisations that need to understand where credible opportunities are emerging, how the risks differ and what is required to act with discipline.

THE DECISIONS I HELP SOLVE
  • 01

    For family offices, private banks, institutional investors and investment committees

    Should we allocate capital to women's health?

    I help investors examine:

    • Whether the opportunity warrants a strategic allocation
    • Where it could fit within an existing portfolio
    • Which forms of exposure are appropriate
    • How specialist managers should be assessed
    • What governance and diligence are required
  • 02

    For investors evaluating specialist healthcare opportunities

    Where are the strongest investment opportunities?

    Women's health spans biotechnology, pharmaceuticals, diagnostics, medical devices, care delivery, digital health and Healthcare AI. Each carries different clinical, regulatory, commercial and investment risks. I help investors distinguish unmet need from investable opportunity and evaluate where scientific progress, enabling technology and viable economics are beginning to converge.

  • 03

    For specialist fund managers and established healthcare businesses

    How do we become credible to institutional capital?

    A compelling product or investment thesis is rarely sufficient. Investors also need clear evidence, credible economics and confidence in the strategy and team.

    I help organisations strengthen:

    • Institutional positioning
    • Investment narratives
    • Capital readiness
    • Diligence preparation
    • Strategic communication before important investor conversations
  • 04

    For healthcare companies, insurers and leadership teams

    What does women's health mean for our organisation?

    I help leadership teams interpret changes in women's health and Healthcare AI, identify their commercial implications and determine where the organisation can build a credible position.

WAYS TO ENGAGE

Every engagement begins with a clearly defined decision.

  • Strategic Advisory

    Defined engagements for investors and organisations facing an important capital, positioning or market-development decision.

  • Executive Briefings

    Private sessions for family offices, investment committees, boards and leadership teams requiring a rigorous perspective on women's-health investing.

  • Keynote Speaking

    Authoritative presentations on women's-health investment, institutional capital allocation and the infrastructure required to make emerging healthcare opportunities investable.

“The hardest investment decisions are made before markets become obvious.”

SPEAKING & EXECUTIVE BRIEFINGS

Maryann speaks internationally with investors, healthcare leaders and institutions on:

EXPLORE SPEAKING & EXECUTIVE BRIEFINGS →
  • The Billion Dollar Blindspot
  • How Investors Can Invest in Women's Health
  • Building the Investment Infrastructure for Women's Health
  • The Great Wealth Transfer and Women's-Health Investing
  • Women's Health, Healthcare AI and the Future of Capital
START A CONVERSATION

If your organisation is navigating one of these decisions, I would be pleased to hear more.

START AN ENQUIRY